PLACEBO TO MATCH INFIGRATINIB SPRINKLE CAPSULES, INFIGRATINIB, INFIGRATINIB, INFIGRATINIB, INFIGRATINIB, Infigratinib clinical trials

A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Infigratinib in Children 3 to <18 Years of Age with Achondroplasia: PROPEL 3

This study is testing a new medicine, Infigratinib, for children aged 3 to under 18 with achondroplasia. It aims to see if the medicine helps children grow taller and improves other health aspects, compared to a dummy pill.